Camp Cgmp
Camp Cgmp - Related Videos
06:03
Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ
0 Views •
Cited by 1 •
2024
The protocol presented in this study illustrates the effectiveness of the cAMP Difference Detector In Situ in measuring cAMP through two methods. One method utilizes a 96-well plate reading spectrophotometer with HEK-293 cells. The other method demonstrates individual HASM cells under a fluorescent microscope.
01:25
cAMP-dependent Protein Kinase Pathways
0 Views •
2023
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
07:36
Mechanical Ventilation Boot Camp Curriculum
0 Views •
Cited by 3 •
2018
This curriculum outlines how to execute a simulation-based boot camp to teach providers how to manage mechanically ventilated patients.
12:33
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
0 Views •
Cited by 54 •
2014
Assaying in vitro β-cell function using isolated mouse islets of Langerhans is an important component in the study of diabetes pathophysiology and therapeutics. While many downstream applications are available, this protocol specifically describes the measurement of intracellular cyclic adenosine monophosphate (cAMP) as an essential parameter determining β-cell function.
09:11
Live-cell Measurement of Odorant Receptor Activation Using a Real-time cAMP Assay
0 Views •
Cited by 13 •
2017
Characterizing the function of odorant receptors serves an indispensable part in the deorphanization process. We describe a method to measure the activation of odorant receptors in real time using a cAMP assay.
FAQs
Receptor-linked adenylyl cyclase converts ATP into cAMP, whereas guanylyl cyclase converts GTP into cGMP. The amount of each messenger therefore reflects the balance between cyclase activity and subsequent degradation. Pharmacological stimulation or inhibition of receptors and cyclases can shift this balance, changing the strength or duration of intracellular responses.
Protein kinases and ion channels translate changes in cyclic nucleotide concentration into functional cellular effects. Kinases modify target proteins, while ion channels influence electrical or ionic behavior. Because these downstream effectors connect messenger levels with cell activity, altering cAMP or cGMP signaling can affect processes such as cardiac activity, neuronal signaling, and smooth-muscle behavior.
Phosphodiesterases help terminate cyclic nucleotide signals by controlling the breakdown of cAMP and cGMP. Their activity limits how long messenger-dependent effects persist after receptor or cyclase stimulation. In pharmacology, modifying phosphodiesterase activity provides a way to regulate signal duration and intensity without directly changing the initiating extracellular stimulus.
The pathways use different cyclases and nucleotide substrates: adenylyl cyclase produces cAMP from ATP, while guanylyl cyclase produces cGMP from GTP. Both can regulate protein kinases, ion channels, and cellular functions, but pharmacological effects depend on which receptor, cyclase, phosphodiesterase, and downstream targets are affected in the relevant cells.
A practical analysis begins by applying an agent that activates or inhibits a receptor, cyclase, or phosphodiesterase, then assessing the resulting change in cAMP or cGMP signaling. Investigators can relate messenger changes to downstream kinase or ion-channel responses and finally to cellular outcomes, such as altered smooth-muscle relaxation or cardiac activity.
These pathways become relevant when a drug is intended to modify smooth-muscle relaxation, cardiac activity, neuronal signaling, or sensory processes. A compound may act at the receptor, cyclase, or phosphodiesterase level, allowing researchers to connect molecular intervention with a physiological response. The same framework also helps interpret therapeutic effects and adverse reactions.
Changes in cAMP or cGMP can indicate whether a pharmacological agent has engaged its intended signaling pathway. Comparing messenger concentrations with protein-kinase, ion-channel, or cellular responses helps distinguish pathway activation from downstream effects. This information supports evaluation of drug action and can reveal signaling changes associated with unwanted reactions.